scholarly journals Consistent superiority of selective serotonin reuptake inhibitors over placebo in reducing depressed mood in patients with major depression

2015 ◽  
Vol 21 (4) ◽  
pp. 523-530 ◽  
Author(s):  
F Hieronymus ◽  
J F Emilsson ◽  
S Nilsson ◽  
E Eriksson
Keyword(s):  
Major Depression ◽  
Depressed Mood ◽  
Serotonin Reuptake ◽  
Selective Serotonin Reuptake Inhibitors ◽  
Serotonin Reuptake Inhibitors ◽  
Selective Serotonin

scholarly journals Commentary: “Consistent Superiority of Selective Serotonin Reuptake Inhibitors Over Placebo in Reducing Depressed Mood in Patients with Major Depression”

2015 ◽  
Vol 6 ◽  
Author(s):  
Eiko I. Fried ◽  
Lynn Boschloo ◽  
Claudia D. van Borkulo ◽  
Robert A. Schoevers ◽  
Jan-Willem Romeijn ◽  
...  
Keyword(s):  
Major Depression ◽  
Depressed Mood ◽  
Serotonin Reuptake ◽  
Selective Serotonin Reuptake Inhibitors ◽  
Serotonin Reuptake Inhibitors ◽  
Selective Serotonin

scholarly journals Optimal dose of selective serotonin reuptake inhibitors, venlafaxine, and mirtazapine in major depression: a systematic review and dose-response meta-analysis

2019 ◽  
Vol 6 (7) ◽  
pp. 601-609 ◽  
Author(s):  
Toshi A Furukawa ◽  
Andrea Cipriani ◽  
Philip J Cowen ◽  
Stefan Leucht ◽  
Matthias Egger ◽  
...  
Keyword(s):  
Systematic Review ◽  
Major Depression ◽  
Dose Response ◽  
Serotonin Reuptake ◽  
Selective Serotonin Reuptake Inhibitors ◽  
Meta Analysis ◽  
Optimal Dose ◽  
Serotonin Reuptake Inhibitors ◽  
Selective Serotonin

Partial Response, Nonresponse, and Relapse With Selective Serotonin Reuptake Inhibitors in Major Depression

2000 ◽  
Vol 61 (6) ◽  
pp. 403-408 ◽  
Author(s):  
Steffany J. Fredman ◽  
Maurizio Fava ◽  
Allison S. Kienke ◽  
Candace N. White ◽  
Andrew A. Nierenberg ◽  
...  
Keyword(s):  
Major Depression ◽  
Partial Response ◽  
Serotonin Reuptake ◽  
Selective Serotonin Reuptake Inhibitors ◽  
Serotonin Reuptake Inhibitors ◽  
Selective Serotonin

scholarly journals Selective serotonin reuptake inhibitors are still harmful and ineffective. Responses to the comments by Hieronymus et al.

2019 ◽  
Vol 31 (05) ◽  
pp. 276-284 ◽  
Author(s):  
Kiran Kumar Katakam ◽  
Naqash Javaid Sethi ◽  
Janus Christian Jakobsen ◽  
Christian Gluud
Keyword(s):  
Systematic Review ◽  
Major Depression ◽  
Serotonin Reuptake ◽  
Selective Serotonin Reuptake Inhibitors ◽  
Review Process ◽  
Serotonin Reuptake Inhibitors ◽  
Selective Serotonin ◽  
Systematic Review Process

AbstractIn this response, we address point by point the additional issues raised by Hieronymus et al. in their second round of critique of our systematic review on selective serotonin reuptake inhibitors for major depression. We repulse that we are biased or mistaken in any major ways. We acknowledge that we missed a few small, mostly unpublished trials, and we made a few minor errors in our systematic review. However, these omissions and errors neither have any impact on our overall results nor on our conclusions. The critique by Hieronymus et al. seems to raise questions about their understanding of the systematic review process, and, on several occasions, they wrongly claimed that we made errors. Our analyses should be impartial and free from any biases or prejudices as we do not have any obligation to support the interests of sponsors or other groups.

Sign in / Sign up

Export Citation Format

Share Document